title: Reduced bone mass and increased bone turnover in postmenopausal women with epilepsy using antiepileptic drug monotherapy.
abstract: OBJECTIVE
  The aims of this study were to assess the occurrence of osteoporosis and fracture rate in Norwegian postmenopausal women with epilepsy using antiepileptic drugs (AEDs), and to investigate how AEDs may affect bone health.
  
  
  METHODS
  Twenty-six female patients receiving AED monotherapy and 26 individually matched healthy controls answered questions about their general health, lifestyle and previous fractures. For both groups, bone mineral density (BMD) was measured by DEXA, and serum samples were analysed for biochemical bone turnover markers and haematological parameters.
  
  
  RESULTS
  The patients, particularly those treated with enzyme-inducing AEDs, had significantly lower BMD than the controls. Additionally, 62 % of the women with epilepsy had osteoporotic T-values in one or more regions, compared with 27 % in the control group. There was a non-significant tendency towards an increased fracture rate among the patients. Markers for bone formation (ALP, bALP, osteocalcin) and bone resorption (Crosslaps) were elevated in the patient group compared with the controls.
  
  
  CONCLUSIONS
  Compared with the healthy controls, we found an increased occurrence of osteoporosis, probably due to increased bone turnover, among Norwegian postmenopausal women with epilepsy undergoing AED monotherapy, which may render these women especially vulnerable to fractures.
authors.affiliation: Department of Neurology, Division for Clinical Neuroscience, Section for Adult Epileptology, Rikshospitalet University Hospital, Oslo, Norway.
authors.forename: Merete Alice
authors.initials: MA
authors.lastname: Lyngstad-Brechan
authors.forename: Erik
authors.initials: E
authors.lastname: Taubøll
authors.forename: Karl Otto
authors.initials: KO
authors.lastname: Nakken
authors.forename: Leif
authors.initials: L
authors.lastname: Gjerstad
authors.forename: Kristin
authors.initials: K
authors.lastname: Godang
authors.forename: Rune
authors.initials: R
authors.lastname: Jemtland
authors.forename: Jens
authors.initials: J
authors.lastname: Bollerslev
mesh_terms: D000368:Aged; D000927:Anticonvulsants / Q000494:pharmacology / Q000627:therapeutic use*; D015519:Bone Density / Q000187:drug effects / Q000502:physiology; D016723:Bone Remodeling / Q000187:drug effects / Q000502:physiology*; D001842:Bone and Bones / Q000187:drug effects / Q000473:pathology* / Q000503:physiopathology; D016022:Case-Control Studies; D003710:Demography; D004827:Epilepsy / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D050723:Fractures, Bone / Q000150:complications / Q000503:physiopathology; D006405:Hematology; D006801:Humans; D008875:Middle Aged; D009929:Organ Size / Q000187:drug effects; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000503:physiopathology; D017698:Postmenopause / Q000187:drug effects / Q000502:physiology*
chemical_list: D000927:Anticonvulsants